• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1血浆病毒对补体介导的裂解作用的敏感性。体内病毒清除作用中一个作用的证据。

Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.

作者信息

Sullivan B L, Knopoff E J, Saifuddin M, Takefman D M, Saarloos M N, Sha B E, Spear G T

机构信息

Department of Immunology/Microbiology, Rush University, Chicago, IL 60612, USA.

出版信息

J Immunol. 1996 Aug 15;157(4):1791-8.

PMID:8759769
Abstract

This study was undertaken to directly assess the susceptibility of HIV-1 plasma virus to C-mediated lysis. Plasma from HIV-infected individuals was collected and ultracentrifuged over 20% sucrose to isolate virions from plasma components including anticoagulants, which inhibit C activity. Treatment with C alone in the absence of exogenously added Ab caused lysis of virus from all patients (n = 18) (range 14 to 86%). This lysis occurred via the classical C pathway and was not due to cross-reactive Abs in the C source. Protein A bound a fraction of isolated plasma virus and this binding was blocked by purified human Ig suggesting that anti-HIV Abs bound to plasma virus could be responsible for inducing C activation. A portion of virus bound to CR2 on cells in the absence of exogenously added C indicating that virus activated C in vivo. C levels from six of six patients were determined to be sufficient to lead to lysis of virus in vivo. Since plasma virus appeared more sensitive to C than primary isolates, isolated virus was evaluated for the presence of C control proteins. While primary isolate virions contained CD46, CD55, and CD59, only CD59 was detected on plasma virus. The results of this study strongly suggest that C is activated by a portion of plasma virus in vivo due to the binding of Ab. The resultant opsonization plus subsequent lysis may be important routes of clearance and destruction of plasma virus in infected persons.

摘要

本研究旨在直接评估HIV-1血浆病毒对补体(C)介导裂解的敏感性。收集HIV感染个体的血浆,并在20%蔗糖上进行超速离心,以从包括抗凝剂在内的血浆成分中分离病毒粒子,抗凝剂会抑制补体活性。在没有外源添加抗体的情况下,仅用补体处理导致所有患者(n = 18)的病毒裂解(范围为14%至86%)。这种裂解通过经典补体途径发生,并非由于补体来源中的交叉反应性抗体。蛋白A结合了一部分分离的血浆病毒,这种结合被纯化的人Ig阻断,表明与血浆病毒结合的抗HIV抗体可能是诱导补体激活的原因。在没有外源添加补体的情况下,一部分病毒与细胞上的CR2结合,表明病毒在体内激活补体。确定六名患者中有六名的补体水平足以在体内导致病毒裂解。由于血浆病毒似乎比原代分离株对补体更敏感,因此评估分离病毒中补体控制蛋白的存在情况。虽然原代分离病毒粒子含有CD46、CD55和CD59,但在血浆病毒上仅检测到CD59。这项研究的结果强烈表明,由于抗体的结合,补体在体内被一部分血浆病毒激活。由此产生的调理作用以及随后的裂解可能是感染个体中血浆病毒清除和破坏的重要途径。

相似文献

1
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.HIV-1血浆病毒对补体介导的裂解作用的敏感性。体内病毒清除作用中一个作用的证据。
J Immunol. 1996 Aug 15;157(4):1791-8.
2
Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.补体调控蛋白CD46、CD55和CD59,作为人类和猿猴免疫缺陷病毒的常见表面成分以及疫苗保护的可能靶点。
Virology. 1994 Nov 15;205(1):82-92. doi: 10.1006/viro.1994.1622.
3
Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.细胞膜CD59的水平调节补体介导的人黑色素瘤细胞裂解程度。
Lab Invest. 1996 Jan;74(1):33-42.
4
Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).宿主细胞衍生的补体调节蛋白CD55和CD59被整合到两种不相关的包膜病毒——人类I型T细胞白血病/淋巴瘤病毒(HTLV-I)和人巨细胞病毒(HCMV)的病毒粒子中。
J Immunol. 1995 Nov 1;155(9):4376-81.
5
Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.葡萄膜黑色素瘤中补体激活的膜结合调节因子。葡萄膜黑色素瘤中的CD46、CD55和CD59。
Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1884-91.
6
Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.1型人类免疫缺陷病毒整合了糖基磷脂酰肌醇锚定的CD55和CD59以及整合膜蛋白CD46,其整合水平可保护病毒免受补体介导的破坏。
J Gen Virol. 1997 Aug;78 ( Pt 8):1907-11. doi: 10.1099/0022-1317-78-8-1907.
7
Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism.补体可通过一种不依赖C5的机制中和HIV-1血浆病毒。
Virology. 1998 Sep 1;248(2):173-81. doi: 10.1006/viro.1998.9289.
8
Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.人滋养层细胞对人补体杀伤的易感性及补体调节蛋白的作用。
J Immunol. 1993 Aug 1;151(3):1562-70.
9
Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.CD59功能的阻断可恢复中和抗体和非中和抗体在触发抗体依赖性补体介导的HIV-1病毒体及前病毒激活的潜伏感染细胞裂解中的活性。
J Virol. 2015 Sep;89(18):9393-406. doi: 10.1128/JVI.01614-15. Epub 2015 Jul 1.
10
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.抗原呈递细胞外泌体通过表达CD55和CD59来免受补体介导的溶解作用。
Eur J Immunol. 2003 Feb;33(2):522-31. doi: 10.1002/immu.200310028.

引用本文的文献

1
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies.抗 SARS-CoV-2 抗体控制 SARS-CoV-2 感染引起的补体炎症反应。
EMBO J. 2024 Apr;43(7):1135-1163. doi: 10.1038/s44318-024-00061-0. Epub 2024 Feb 28.
2
Nanobody-mediated complement activation to kill HIV-infected cells.纳米抗体介导的补体激活杀伤感染 HIV 的细胞。
EMBO Mol Med. 2023 Apr 11;15(4):e16422. doi: 10.15252/emmm.202216422. Epub 2023 Feb 17.
3
Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.
共感染而非序贯感染树突状细胞可增强其刺激 HIV 特异性 CTL 的能力。
Front Immunol. 2019 May 24;10:1123. doi: 10.3389/fimmu.2019.01123. eCollection 2019.
4
Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.分析补体介导的猴免疫缺陷病毒(SIV)和感染 SIV 的细胞的溶解作用揭示了恒河猴疫苗诱导免疫反应中的性别差异。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00721-18. Print 2018 Oct 1.
5
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.V1V2特异性补体激活血清IgG作为RV144中HIV-1感染风险降低的一个相关因素。
PLoS One. 2017 Jul 5;12(7):e0180720. doi: 10.1371/journal.pone.0180720. eCollection 2017.
6
Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.在艾滋病毒/艾滋病的猕猴模型中,HLA抗体介导的补体介导的病毒感染性中和作用与对SIV攻击的无菌免疫相关。
PLoS One. 2014 Feb 14;9(2):e88735. doi: 10.1371/journal.pone.0088735. eCollection 2014.
7
Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.丙型肝炎病毒 NS3/4A 蛋白酶通过切割补体成分 4 抑制补体激活。
PLoS One. 2013 Dec 12;8(12):e82094. doi: 10.1371/journal.pone.0082094. eCollection 2013.
8
Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.补体对 HIV-2 血浆抗病毒活性的影响具有同种型特异性和高效性。
J Virol. 2013 Jan;87(1):273-81. doi: 10.1128/JVI.01640-12. Epub 2012 Oct 17.
9
The role of humoral innate immunity in hepatitis C virus infection.体液固有免疫在丙型肝炎病毒感染中的作用。
Viruses. 2012 Jan;4(1):1-27. doi: 10.3390/v4010001. Epub 2012 Jan 5.
10
Mechanisms of Host Resistance Against HIV Infection and Progression to AIDS.宿主抵抗HIV感染及进展至艾滋病的机制。
Sultan Qaboos Univ Med J. 2007 Aug;7(2):82-96.